» Articles » PMID: 31371941

NIR-guided Dendritic Nanoplatform for Improving Antitumor Efficacy by Combining Chemo-phototherapy

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2019 Aug 3
PMID 31371941
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phototherapy, including photothermal therapy (PTT) and photodynamic therapy (PDT), is a promising noninvasive strategy in the treatment of cancers due to its highly localized specificity to tumors and minimal side effects to normal tissues. However, single phototherapy often causes tumor recurrence which hinders its clinical applications. Therefore, developing a NIR-guided dendritic nanoplatform for improving the phototherapy effect and reducing the recurrence of tumors by synergistic chemotherapy and phototherapy is essential.

Methods: A fluorescent targeting ligand, insisting of ICG derivative cypate and a tumor penetration peptide iRGD (CRGDKGPDC), was covalently combined with PAMAM dendrimer to prepare a single agent-based dendritic theranostic nanoplatform iRGD-cypate-PAMAM-DTX (RCPD).

Results: Compared with free cypate, the resulted RCPD could generate enhanced singlet oxygen species while maintaining its fluorescence intensity and heat generation ability when subjected to NIR irradiation. Furthermore, our in vitro and in vivo therapeutic studies demonstrated that compared with phototherapy or chemotherapy alone, the combinatorial chemo-photo treatment of RCPD with the local exposure of NIR light can significantly improve anti-tumor efficiency and reduce the risk of recurrence of tumors.

Conclusion: The multifunctional theranostic platform (RCPD) could be used as a promising method for NIR fluorescence image-guided combinatorial treatment of tumor cancers.

Citing Articles

NIR Triggered Bionic Bilayer Membrane-Encapsulated Nanoparticles for Synergistic Photodynamic, Photothermal and Chemotherapy of Cervical Cancer.

Ding J, Zhang X, Guo L, Xiong J, Zhang C, Du Z Int J Nanomedicine. 2025; 20():141-159.

PMID: 39802385 PMC: 11721149. DOI: 10.2147/IJN.S496982.


Extracellular vesicles: a rising star for therapeutics and drug delivery.

Du S, Guan Y, Xie A, Yan Z, Gao S, Li W J Nanobiotechnology. 2023; 21(1):231.

PMID: 37475025 PMC: 10360328. DOI: 10.1186/s12951-023-01973-5.


Chemosensitivity enhanced by autophagy inhibition based on a polycationic nano-drug carrier.

Li N, Han S, Ma B, Huang X, Xu L, Cao J Nanoscale Adv. 2022; 3(6):1656-1673.

PMID: 36132550 PMC: 9417626. DOI: 10.1039/d0na00990c.


Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity.

Li M, Zhu Y, Yang C, Yang M, Ran H, Zhu Y Drug Deliv. 2022; 29(1):2177-2189.

PMID: 35815688 PMC: 9291667. DOI: 10.1080/10717544.2022.2095058.


Self-assembly of Peptide dendrimers and their bio-applications in theranostics.

Xie F, Li R, Shu W, Zhao L, Wan J Mater Today Bio. 2022; 14:100239.

PMID: 35295319 PMC: 8919296. DOI: 10.1016/j.mtbio.2022.100239.


References
1.
Jin M, Yang B, Zhang W, Ren P . Combined treatment with photodynamic therapy and chemotherapy for advanced cardiac cancers. J Photochem Photobiol B. 1992; 12(1):101-6. DOI: 10.1016/1011-1344(92)85021-l. View

2.
Cardillo J, Jorge R, Costa R, Nunes S, Lavinsky D, Kuppermann B . Experimental selective choriocapillaris photothrombosis using a modified indocyanine green formulation. Br J Ophthalmol. 2008; 92(2):276-80. DOI: 10.1136/bjo.2007.129395. View

3.
Chatterjee D, Fong L, Zhang Y . Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008; 60(15):1627-37. DOI: 10.1016/j.addr.2008.08.003. View

4.
Li L, Xie J, Zhang X, Chen J, Luo Y, Zhang L . Retrospective study of photodynamic therapy vs photodynamic therapy combined with chemotherapy and chemotherapy alone on advanced esophageal cancer. Photodiagnosis Photodyn Ther. 2010; 7(3):139-43. DOI: 10.1016/j.pdpdt.2010.06.002. View

5.
Li Y, Lu W, Huang Q, Huang M, Li C, Chen W . Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine (Lond). 2010; 5(8):1161-71. DOI: 10.2217/nnm.10.85. View